Financial Performance - The company generated revenue of 59.6millionand50.2 million for the years ended December 31, 2024 and 2023, respectively, reflecting a year-over-year increase of 27.7%[393] - The company incurred net losses of 72.2millionand36.4 million for the years ended December 31, 2024 and 2023, respectively, with an accumulated deficit of 242.8millionasofDecember31,2024[395]−TotalrevenuefortheyearendedDecember31,2024,was59.6 million, a 9.4millionincreasefrom50.2 million in 2023[443] - The net loss for 2024 was 72,206,000,comparedtoanetlossof36,399,000 in 2023, indicating a worsening financial position[524] - Cash and cash equivalents decreased to 44,032,000in2024from121,041,000 in 2023, a decline of 63.6%[522] - The company experienced a net decrease in cash, cash equivalents, and restricted cash of 77.0millionin2024,comparedtoadecreaseof67.4 million in 2023[473] Revenue Composition - Recurring revenue accounted for 39% of total revenue in 2024, up from 33% in 2023, indicating a growing reliance on consumables and services[414] - Product revenue increased by 3.7million,or943.9 million for the year ended December 31, 2024, compared to 40.2millionin2023[444]−Serviceandcontractrevenueincreasedsignificantlyby56.515,709,000 from 10,015,000[524]−Devicesalesrevenueincreasedto35,991,000 in 2024 from 33,379,000in2023,agrowthof4.846,238,000, up from 38,240,000in2023,representingagrowthof20.57.6 million, or 16%, to 53.6millionin2024comparedto46.1 million in 2023[443] - Research and development expenses increased by 3.6million,or1625.5 million in 2024 from 21.9millionin2023[443]−Totaloperatingexpensessurgedto106,574,000, a 56.5% increase from 68,080,000in2023,primarilyduetohigherresearchanddevelopmentcosts[524]AcquisitionsandRestructuring−ThecompanycompletedanacquisitionofRedWavefor45.0 million in cash and 1,497,171 shares of common stock, enhancing its portfolio of handheld chemical analysis devices[392] - An organizational restructuring was announced in November 2024, resulting in an approximately 11% workforce reduction to improve operational efficiencies[397] - The company acquired RedWave Technology for 44.8millioninApril2024,enhancingitsportfolioofhandheldchemicalanalysisdevices[536]CashFlowandFinancing−NetcashusedinoperatingactivitiesfortheyearendedDecember31,2024,was30.2 million, an increase from 25.1millionin2023,primarilyduetoanetlossof72.2 million[474][475] - Cash used in investing activities increased significantly to 46.3millionin2024from26.4 million in 2023, largely due to the acquisition of RedWave for 44.8million[476][477]−Cashusedinfinancingactivitiesdecreasedto0.4 million in 2024 from 15.9millionin2023,primarilyduetoapaymentforcontingentconsiderationrelatedtotheacquisitionofTraceAnalyticsGmbH[478][479]GoodwillandImpairment−Agoodwillimpairmentof40.7 million was recorded for the year ended December 31, 2024, representing 68% of total revenue[454] - The company recorded a goodwill impairment of 40,659,000in2024,reflectingsignificantchangesinassetvaluation[524]MarketandEconomicFactors−Thecompanyiscloselymonitoringmacroeconomicfactors,includinginflationandinterestrates,whichmayimpactcustomerspendingandpurchasingpatterns[401]−ThecompanyexpectstotransitionmanufacturingoperationsfromMassachusettstoNorthCarolinaandConnecticutthroughout2025,withassociatedcostsanticipated[399]CustomerandRevenueConcentration−Onecustomeraccountedfor1546,161,000 in 2024, an increase of 20.5% from $38,232,000 in 2023[586] Future Outlook - The company expects gross profit margins to increase over the long term as sales and production volumes rise and costs per unit decrease[431] - The company anticipates that its cash and marketable securities will be sufficient to fund operations for at least the next 12 months[539] - The company expects to continue generating operating losses in the foreseeable future, indicating ongoing financial challenges[539]